Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Lumedica Vision develops LumAI, software that uses AI to analyze retinal OCT imaging data and compares it against a database of known eye diseases to flag suspected pathology and support physician decision-making. The tool is designed for eye care providers to enable automated image classification at the point of care and expand screening for treatable retinal disease before vision loss.
0 investors
Lumina Pharmaceuticals is a clinical-stage company that develops diagnostic and therapeutic radiopharmaceuticals using peptide technology.
0 investors
Lumitex designs and manufactures specialized lighting solutions for medical devices and industrial applications. The company provides engineering services, guidance on lighting technology selection, and in-house production to help customers integrate innovative lighting into their products.
0 investors
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
0 investors
Marius Pharmaceuticals develops therapies for hormonal and metabolic health, with a focus on treating testosterone deficiency and hypogonadism in men and women. The company works in the pharmaceutical and biotech space, offering research-based treatments aimed at improving hormone balance and metabolic function.
0 investors
MarvelBiome is a clinical-stage biotechnology company developing Live Biotherapeutic Products through engineered bacterial consortia designed to treat disease-specific conditions. The company focuses on microbiome-based treatments for patients.
0 investors
Mati Therapeutics develops a non-invasive sustained drug delivery platform, the Evolute Punctal Plug Delivery System, for treating ocular diseases such as glaucoma. The device delivers medication over an extended period, removing the need for patients to administer eye drops.
0 investors
Maverix Oncology develops conditionally activated small molecule therapeutics for cancer treatment, led by a team of oncologists and cancer scientists with experience in drug discovery and development.
0 investors
MAXONA Pharmaceuticals develops non-opioid pain treatment options for the U.S. market. The company is focused on expanding therapeutic alternatives in pain management.
0 investors
MD Hyperbaric operates medically-supervised hyperbaric oxygen therapy (HBOT) centers nationwide, treating conditions including chronic wounds and neurological injuries by delivering oxygen in pressurized environments. The company serves patients seeking non-invasive therapeutic treatment for healing and recovery.
0 investors
MDM Wound Ventures develops evidence-based wound care solutions, including products based on medicinal honey research, for clinicians treating homecare patients. It focuses on advancing wound healing with reduced patient pain.
0 investors
MedaSync provides software to skilled nursing facilities (SNFs) for managing revenue cycles and administrative processes under new Medicare payment models. The platform helps post-acute care operators automate operations and improve revenue integrity in response to changes in healthcare reimbursement systems.
0 investors
Medaxion develops software platforms for operating room and anesthesia management, helping OR leaders optimize staffing, manage finances, and track performance through real-time data analytics and EHR solutions for anesthesia practices and hospitals.
0 investors
Medical 21 develops the MAVERICS Graft, a synthetic regenerative vascular graft that lets surgeons perform complete cardiac bypass procedures without harvesting the patient's own blood vessels. The graft uses a nitinol scaffold and stimulates angiogenesis so the body forms an arterial-like vessel from the patient's own cells, targeting coronary bypass surgery.
0 investors
Medical Lodges is a healthcare services provider focused on delivering quality health services to customers and communities through compassionate care.
0 investors
MEDILOGIX is a tech-enabled healthcare services platform for medical equipment management, offering rental management, field operations tools, analytics portals, and proprietary products such as CareMatt for care providers. It serves post-acute care facilities in the United States, with software including MxMobile, MxPortal, and its rental-as-a-service (RaaS) offering.
0 investors
MediPines develops the AGM100, an FDA-cleared medical device for non-invasive assessment of respiratory and cardiovascular status in healthcare settings. The company serves emergency, acute, and chronic care providers across North America and is expanding globally.
0 investors
Meditope is a biotechnology company developing SnAP technology for antibody design, with a focus on creating more efficacious, safer, and cost-efficient antibody-based therapeutic products.
0 investors
MedServ operates a marketplace for healthcare equipment services, connecting service providers with healthcare facilities and organizations. The platform facilitates the procurement and management of equipment maintenance and repair solutions.
0 investors
MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
0 investors
MedWatch Technologies develops a non-invasive wearable glucose monitoring platform using microwave-based sensing technology for diabetes management. The company is advancing the technology from in-human testing toward commercialization for patients requiring continuous glucose monitoring.
0 investors
Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.
0 investors
A surgical center operating under SCA Health that provides outpatient surgery and procedures for patients. The center emphasizes clinical quality and service excellence in ambulatory surgery and gastroenterology procedures.
0 investors
A clinical-stage biotech company developing novel drugs based on isotope-selective modulation technology, with patented drug compositions and a proprietary development platform currently in clinical trials.
0 investors